文献速递瓣膜外科

闭胸机器人对比端口入路二尖瓣修复的术后结局

Closed-Chest Robotic vs Port Access Approach for Mitral Repair: Comparison of Postoperative Outcomes.
PubMed 文献 · Ann Thorac Surg · 2026-04-13

该回顾性研究纳入2012-2025年因二尖瓣脱垂致孤立性重度反流行二尖瓣修复的患者306例(闭胸机器人117例,端口入路189例),倾向性匹配后107对。两组修复率均100%,无中转,主要并发症无差异;闭胸机器人组手术、体外循环和阻断时间更短,引流少、术后房颤和感染率更低、住院更短。

要点

  • 闭胸机器人二尖瓣修复安全有效,修复率100%且无中转。
  • 闭胸机器人组手术、体外循环和阻断时间分别缩短25、18、21分钟。
  • 闭胸机器人组引流少、房颤和感染率更低、住院更短。

核心结论

  • 闭胸机器人入路是择期二尖瓣修复中端口入路的安全有效替代方案。
  • 仍需前瞻性随机研究进一步明确其临床影响。

研究设计与样本

  • 回顾性分析2012-2025年因二尖瓣脱垂致孤立性重度反流行闭胸机器人或端口入路二尖瓣修复的患者。
  • 共纳入306例(闭胸机器人117例,端口入路189例),倾向性匹配1:1后107对。

主要发现

  • 两组修复率均100%,无中转,手术死亡极少,主要并发症少见且组间无差异。
  • 闭胸机器人组总手术、体外循环和阻断时间分别缩短25、18、21分钟(P < 0.001)。
  • 闭胸机器人组引流145 mL vs 300 mL(P < .001),术后房颤11% vs 25%(P = .003),感染0% vs 5%(P = .017),住院3天 vs 7天(P < .001)。
  • 5例(闭胸机器人1例,端口入路4例)因出院前超声欠佳于住院期间再次修复,均成功。
  • 99.3%患者出院时二尖瓣反流轻度或以下;2年免于重度反流闭胸机器人组96%、端口入路组94%。

关键数值与推荐

  • 主要并发症包括卒中0.3%、延长机械通气2%、急性肾损伤1%、起搏器植入2%、因出血再干预3.2%,组间无差异。

临床怎么用

  • 对于择期二尖瓣脱垂致重度反流的修复,闭胸机器人入路可考虑作为端口入路的替代。
  • 闭胸机器人入路可能缩短手术时间和住院时间,并降低术后房颤和感染风险。

局限性

  • 本研究为回顾性分析,需前瞻性随机研究进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A trocar-only approach has recently been proposed for mitral valve repair. This closed-chest robotic-assisted (CCR) mitral valve repair completely avoids minithoracotomy, thereby potentially enhancing surgical efficiency and maximizing the benefits of robotic technology. We aimed to compare this approach with the port-access approach. METHODS: This study was a retrospective analysis of patients undergoing surgery using CCR or a port-access approach for isolated severe mitral regurgitation secondary to mitral prolapse (2012-2025). A 1:1 propensity-matched cohort was analyzed. RESULTS: A total of 306 patients were included (CCR, 117; port-access, 189), with 107 matched pairs after propensity adjustment. Repair rates were 100% in both groups with no conversions. Operative mortality was negligible, and major complications were infrequent, including stroke (0.3%), prolonged mechanical ventilation (2%), acute kidney injury (1%), pacemaker implantation (2%), and reintervention for bleeding (3.2%), without group differences. The CCR approach showed shorter total operative, bypass, and cross-clamp times (-25, -18, and -21 minutes; P < 0.001). Postoperative outcomes favored CCR, with lower drainage output (145 mL vs 300 mL; P < .001), postoperative atrial fibrillation (11% vs 25%; P = .003), and infection rate (0% vs 5%; P = .017), as well as a shorter hospital stay (3 days vs 7 days; P < .001). Five patients (1 CCR and 4 port-access) required early repeat repair during the index admission as a result of suboptimal predischarge echocardiography; all patients underwent successful repairs using the same approach. Overall, 99.3% of patients were discharged with mild or less mitral regurgitation. At 2 years, freedom from severe regurgitation was 96% in the CCR group and 94% in the port-access group. CONCLUSIONS: The CCR approach is a safe and effective alternative to the port-access approach for elective mitral valve repair. Prospective randomized studies are needed to define its clinical impact further.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Ascaso M, Sandoval E, Morales-Rey I, et al. Closed-Chest Robotic vs Port Access Approach for Mitral Repair: Comparison of Postoperative Outcomes. Ann Thorac Surg. 2026. PMID: 41985604. doi:10.1016/j.athoracsur.2026.03.068

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。